EP.13B.08 Enhanced Efficacy of Anlotinib in Small Cell Lung Cancer after Immune Checkpoint Inhibitor Exposure
Back to course
Pdf Summary
Asset Subtitle
Jianzhen Shan
Meta Tag
Speaker Jianzhen Shan
Topic Small Cell Lung Cancer and Neuroendocrine Tumors
Keywords
anlotinib
anti-angiogenic
third-line treatment
extensive-stage small cell lung cancer
immune checkpoint inhibitors
progression-free survival
overall survival
adverse events
retrospective analysis
ECOG performance status
Powered By